NCT01822288View on ClinicalTrials.gov

The Impact of Hormone Therapy on Lower Urinary Tract Symptoms, Sexual Function and Psychosomatic Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

November 16, 2012

Primary Completion Date

July 8, 2021

Study Completion Date

August 26, 2021

Conditions
Menopausal Syndromes
Interventions
DRUG

Tibolone

Tibolone 2.5 mg once a day for patients with menopausal syndrome (self-paid)

DRUG

Estradiol & medroxyprogesterone acetate

Estradiol \& medroxyprogesterone acetate once a day for patients with menopausal syndromes, for patients without the need for self-paid drug

Trial Locations (1)

220

Far Eastern Memorial Hospital, Banqiao District

All Listed Sponsors
lead

Far Eastern Memorial Hospital

OTHER

NCT01822288 - The Impact of Hormone Therapy on Lower Urinary Tract Symptoms, Sexual Function and Psychosomatic Disorder | Biotech Hunter | Biotech Hunter